The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
The biology and chemistry of hyperlipidemia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,405
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Possible molecular mechanisms of the protonmotive function of cytochrome systems
Mitchell, P. (1976) · Journal of Theoretical Biology · doi:10.1016/0022-5193(76)90124-7 · Cited by 1,268
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
Smith, S. J., Cases, S., Jensen, D. R., Chen, H. C., Sande, E., Tow, B., Sanan, D. A., Raber, J., Eckel, R. H., & Farese, R. V. (2000) · Nature Genetics · doi:10.1038/75651 · Cited by 896
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 870
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Rosamond, W. D., Chambless, L. E., Folsom, A. R., Cooper, L. S., Conwill, D. E., Clegg, L., Wang, C.-H., & Heiss, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391301 · Cited by 827
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Influence of nicotinic acid on serum cholesterol in man
Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 724
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Biological Activity of Some Oxygenated Sterols
Kandutsch, A. A., Chen, H. W., & Heiniger, H.-J. (1978) · Science · doi:10.1126/science.663671 · Cited by 571
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Editorial: A System for Phenotyping Hyperlipoproteinemia
FREDRICKSON, D. S., & LEES, R. S. (1965) · Circulation · doi:10.1161/01.cir.31.3.321 · Cited by 507
Miller, N. E., Hammett, F., Saltissi, S., Rao, S., van Zeller, H., Coltart, J., & Lewis, B. (1981) · BMJ · doi:10.1136/bmj.282.6278.1741 · Cited by 482
de Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F. H., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000015857.31889.7b · Cited by 456
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 438
Barbier, O., Torra, I. P., Duguay, Y., Blanquart, C., Fruchart, J.-C., Glineur, C., & Staels, B. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000015598.86369.04 · Cited by 416
Chang, C. C., Huh, H. Y., Cadigan, K. M., & Chang, T. Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36846-2 · Cited by 389
Novel Inflammatory Markers of Coronary Risk: Theory Versus Practice
Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
Paul, A., Ko, K. W. S., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004) · Circulation · doi:10.1161/01.cir.0000114526.50618.24 · Cited by 373
The antioxidant butylated hydroxytoluene protects against atherosclerosis.
Björkhem, I., Henriksson-Freyschuss, A., Breuer, O., Diczfalusy, U., Berglund, L., & Henriksson, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.15 · Cited by 358
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
Shepherd, J., Packard, C. J., Bicker, S., Lawrie, T. D. V., & Morgan, H. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022202 · Cited by 357
Ingold, K. U., Bowry, V. W., Stocker, R., & Walling, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.45 · Cited by 345
Ros, E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00456-1 · Cited by 316
Bays, H. E., Moore, P. B., Drehobl, M. A., Rosenblatt, S., Toth, P. D., Dujovne, C. A., Knopp, R. H., Lipka, L. J., LeBeaut, A. P., Yang, B., et al. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80102-8 · Cited by 311
Biomedical and clinical aspects of coenzyme Q
Littarru, G. P. (1993) · The Clinical Investigator · doi:10.1007/bf00184478 · Cited by 310
Effect of (—)-Hydroxycitrate on Fatty Acid Synthesis by Rat Liver in Vivo
Lowenstein, J. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62460-3 · Cited by 270
An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Tricarballylate and hydroxycitrate: Substrate and inhibitor of ATP: Citrate oxaloacetate lyase
Watson, J. A., Fang, M., & Lowenstein, J. M. (1969) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(69)90532-3 · Cited by 263
Lee, C.-H., Jeong, T.-S., Choi, Y.-K., Hyun, B.-H., Oh, G.-T., Kim, E.-H., Kim, J.-R., Han, J.-I., & Bok, S.-H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5001 · Cited by 254
CLELAND, S. J., SATTAR, N., PETRIE, J. R., FOROUHI, N. G., ELLIOTT, H. L., & CONNELL, J. M. C. (2000) · Clinical Science · doi:10.1042/cs0980531 · Cited by 249
Carnosic acid, a new class of lipid absorption inhibitor from sage
Ninomiya, K., Matsuda, H., Shimoda, H., Nishida, N., Kasajima, N., Yoshino, T., Morikawa, T., & Yoshikawa, M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.091 · Cited by 240
Blair, S. N., Capuzzi, D. M., Gottlieb, S. O., Nguyen, T., Morgan, J. M., & Cater, N. B. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00976-0 · Cited by 236
Knopp, R. H., Ginsberg, J., Albers, J. J., Hoff, C., Ogilvie, J. T., Warnick, G. R., Burrows, E., Retzlaff, B., & Poole, M. (1985) · Metabolism · doi:10.1016/0026-0495(85)90092-7 · Cited by 231
Selective inhibition of acyl coenzyme A:cholesterol acyltransferase by compound 58-035.
Ross, A. C., Go, K. J., Heider, J. G., & Rothblat, G. H. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43530-7 · Cited by 224
Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density Lipoprotein
Bowry, V. W., Mohr, D., Cleary, J., & Stocker, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5756 · Cited by 212
The assembly and secretion of apolipoprotein B-containing lipoproteins
Olofsson, S.-O., Asp, L., & Borén, J. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199908000-00008 · Cited by 210
Statin inhibition of HMG-CoA reductase: a 3-dimensional view
Istvan, E. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00003-5 · Cited by 196
Albers, J. J., Taggart, H. M., Applebaum-Bowden, D., Haffner, S., Chesnut, C. H., & Hazzard, W. R. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90078-x · Cited by 187
Duez, H., Chao, Y.-S., Hernandez, M., Torpier, G., Poulain, P., Mundt, S., Mallat, Z., Teissier, E., Burton, C. A., Tedgui, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206966200 · Cited by 186
Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
Morand, O. H., Aebi, J. D., Dehmlow, H., Ji, Y., Gains, N., Lengsfeld, H., & Himber, J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37449-6 · Cited by 159
Lipoprotein metabolism and its relationship to atherosclerosis
Ginsberg, H. N. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30174-2 · Cited by 157
Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety
Shepherd, J. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.1.5 · Cited by 155
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids
PEARCE, N. J., Yates, J. W., Berkhout, T. A., Jackson, B., Tew, D. G., Boyd, H., Camilleri, P., Sweeney, P. J., Gribble, A. D., Shaw, A. N., et al. (1998) · Biochemical Journal · doi:10.1042/bj3340113 · Cited by 144
Lohray, B. B., Lohray, V. B., Bajji, A. C., Kalchar, S., Poondra, R. R., Padakanti, S., Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Suresh, J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010143b · Cited by 137
Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol
Gelissen, I. C., Brown, A. J., Mander, E. L., Kritharides, L., Dean, R. T., & Jessup, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17852 · Cited by 131
Elshourbagy, N. A., Near, J. C., Kmetz, P., Sathe, G. M., Southan, C., Strickler, J. E., Gross, M. S., Young, J. F., Wells, T. N. C., & Groot, P. H. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40033-1 · Cited by 130
Treatment of essential hypertension with Coenzyme Q10
Langsjoen, P. H., Langsjoen, P. H., Willis, R. A., & Folkers, K. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90037-x · Cited by 129
Brewer, H. B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000121505.88326.d2 · Cited by 128
Largis, E. E., Wang, C.-H., DeVries, V. G., & Schaffer, S. A. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38328-0 · Cited by 125
Regulation of apo A-I gene expression by fibrates
Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 124
Novel coumarin derivatives of heterocyclic compounds as lipid-Lowering agents
Madhavan, G. R., Balraju, V., Mallesham, B., Chakrabarti, R., & Lohray, V. B. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00490-6 · Cited by 116
Reverse Cholesterol Transport—A Review of the Process and Its Clinical Implications
Hill, S., & McQueen, M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00098-2 · Cited by 115
Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues
Wetterau, J. R., & Zilversmit, D. B. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90084-6 · Cited by 112
Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice
Witting, P. K., Pettersson, K. S., Letters, J., & Stocker, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00311-7 · Cited by 103
THE MECHANISM RESPONSIBLE FOR THE ALTERED BLOOD CHOLESTEROL CONTENT IN DERANGED THYROID STATES*†
Rosenman, R. H., BYERS, S. O., & Friedman, M. (1952) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-12-10-1287 · Cited by 103
Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent
Donovan, J. M., Stypinski, D., Stiles, M. R., Olson, T. A., & Burke, S. K. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007831418308 · Cited by 93
Kleinveld, H. A., Demacker, P. N. M., de Haan, A. F. J., & Stalenhoef, A. F. H. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00776.x · Cited by 93
3-β-Hydroxysterol synthesis by the liver
Brunengraber, H., Sabine, J. R., Boutry, M., & Lowenstein, J. M. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90054-9 · Cited by 89
Lipid oxidation in atherogenesis: an overview
Jessup, W., Kritharides, L., & Stocker, R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320134 · Cited by 87
Russell, J. C., Shillabeer, G., Bar‐Tana, J., Lau, D. C., Richardson, M., Wenzel, L., Graham, S. E., & Dolphin, P. J. (1998) · Diabetes · doi:10.2337/diabetes.47.5.770 · Cited by 87
EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN*
Steinberg, D. H., Avigan, J., & Feigelson, E. B. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104323 · Cited by 85
Chrysselis, M. C., Rekka, E. A., & Kourounakis, P. N. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991039l · Cited by 83
Ugawa, T., Kakuta, H., Moritani, H., Matsuda, K., Ishihara, T., Yamaguchi, M., Naganuma, S., Iizumi, Y., & Shikama, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703545 · Cited by 81
Jamil, H., Chu, C.-H., Dickson, J. K., Chen, Y., Yan, M., Biller, S. A., Gregg, R. E., Wetterau, J. R., & Gordon, D. A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32526-8 · Cited by 81
Highlights in Ubiquinone research
(1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90162-m · Cited by 80
Berkhout, T. A., Havekes, L. M., Pearce, N. J., & Groot, P. H. E. (1990) · Biochemical Journal · doi:10.1042/bj2720181 · Cited by 79
Coenzyme Q10 treatment in serious heart failure
Munkholm, H., Hansen, H. H. T., & Rasmussen, K. (1999) · BioFactors · doi:10.1002/biof.5520090225 · Cited by 76
Synthesis and in Vitro Evaluation of Inhibitors of Intestinal Cholesterol Absorption
Kværnø, L., Werder, M., Hauser, H., & Carreira, E. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050422p · Cited by 75
Amin, D., Rutledge, R. Z., Needle, S., Galczenski, H., Neuenschwander, K. W., Scotese, A. C., Maguire, M. P., Bush, R. C., Hele, D. J., Bilder, G. E., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36653-4 · Cited by 69
Inhibition of Enzymes which Interact with Citrate by (—)Hydroxycitrate and 1,2,3,‐Tricarboxybenzene
Cheema‐Dhadli, S., Halperin, M. L., & Leznoff, C. C. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb03038.x · Cited by 67
Roth, B. D., Blankley, C. J., Hoefle, M. L., Holmes, A., Roark, W. H., Trivedi, B. K., Essenburg, A. D., Kieft, K. A., Krause, B. R., & Stanfield, R. L. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00087a016 · Cited by 66
Hiyoshi, H., Yanagimachi, M., Ito, M., Ohtsuka, I., Yoshida, I., Saeki, T., & TANAKA, H. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32020-4 · Cited by 61
Ludwig, E. H., Mahley, R. W., Palaoğlu, E., Özbayrakçı, S., Balestra, M. E., Borecki, I. B., Innerarity, T. L., & Farese, R. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620109.x · Cited by 56
Hypolipidemic activity of (−)‐hydroxycitrate
Sullivan, A. C., Triscari, J. M., Hamilton, J. G. C., & Ontko, J. A. (1977) · Lipids · doi:10.1007/bf02532964 · Cited by 53
SCAP ligands are potent new lipid-lowering drugs
Grand-Perret, T., Bouillot, A., Perrot, A., Commans, S., Walker, M., & Issandou, M. (2001) · Nature Medicine · doi:10.1038/nm1201-1332 · Cited by 52
Datta, G., Garber, D. W., Chung, B. H., Chaddha, M., Dashti, N., Bradley, W. A., Gianturco, S. H., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31620-5 · Cited by 50
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2312 · Cited by 48
Hiyoshi, H., Yanagimachi, M., Ito, M., Yasuda, N., Okada, T., Ikuta, H., Shinmyo, D., Tanaka, K., Kurusu, N., Yoshida, I., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200316-jlr200 · Cited by 48
Naringenin derivatives as anti-atherogenic agents
Lee, S., Lee, C., Moon, S., Kim, E. S., Kim, C., Kim, B., Bok, S., & Jeong, T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.009 · Cited by 39
Mayer, R. J., Adams, J. L., Bossard, M. J., & Berkhout, T. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54892-4 · Cited by 35
Lipid‐lowering effects of WAY‐121,898, an inhibitor of pancreatic cholesteryl ester hydrolase
Krause, B. R., Sliskovic, D. R., Anderson, M. K., & Homan, R. (1998) · Lipids · doi:10.1007/s11745-998-0232-8 · Cited by 35
Gribble, A. D., Dolle, R. E., Shaw, A. N., McNair, D., Novelli, R., Novelli, C. E., Slingsby, B. P., Shah, V. P., Tew, D. G., SAXTY, B. A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960167w · Cited by 35
Antihyperlipidemic Statins: A Self-Contained, Clinically Relevant Medicinal Chemistry Lesson
Roche, V. F. (2005) · American Journal of Pharmaceutical Education · doi:10.1016/s0002-9459(24)08821-1 · Cited by 35
Sharma, A., Slugg, P. H., Hammett, J. L., & Jusko, W. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801205 · Cited by 33
Azalanstat (RS-21607), a lanosterol 14α-demethylase inhibitor with cholesterol-lowering activity
Burton, P. M., Swinney, D. C., Heller, R. A., Dunlap, B., Chiou, M., Malonzo, E., Haller, J., Walker, K. A. M., Salari, A., Murakami, S., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00152-p · Cited by 31
Hypolipidemic effects of NB-598 in dogs
Horie, M., Sawasaki, Y., Fukuzumi, H., Watanabe, K., Iizuka, Y., Tsuchiya, Y., & Kamei, T. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90080-m · Cited by 31
Durley, R. C., Grapperhaus, M. L., Massa, M. A., Mischke, D. A., Parnas, B. L., Fobian, Y. M., Rath, N. P., Honda, D. D., Zeng, M., Connolly, D. T., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000337b · Cited by 31
Peelman, F., Vandekerckhove, J. S., & Rosseneu, M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00008 · Cited by 31
Kubo, M., Matsuzawa, Y., Yokoyama, S., Tajima, S., ISHIKAWA, K., Yamamoto, A., & Tarui, S. (1982) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134000 · Cited by 31
A new feature on the cholesterol-lowering landscape
Rader, D. J. (2001) · Nature Medicine · doi:10.1038/nm1201-1282 · Cited by 28
Lowenstein, J. M., & Brunengraber, H. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)72038-x · Cited by 26
Stereospecific Inhibition of CETP by ChiralN,N-Disubstituted Trifluoro-3-amino-2-propanols
Connolly, D. T., Witherbee, B. J., Melton, M. A., Durley, R. C., Grapperhaus, M. L., McKinnis, B. R., Vernier, W. F., Babler, M. A., Shieh, J.-J. J., Smith, M. E., et al. (2000) · Biochemistry · doi:10.1021/bi001356q · Cited by 22
Cholesteryl ester transfer protein inhibition by PD 140195
Bisgaier, C. L., Essenburg, A. D., Minton, L. L., Homan, R., Blankley, C. J., & White, A. D. (1994) · Lipids · doi:10.1007/bf02536247 · Cited by 18
Emerging non-statin LDL-lowering therapies for dyslipidemia and atherosclerosis.
Shah, P. K. (2003) · PubMed · Cited by 16
ATP-citrate Lyase: A Potential Target for Hypolipidemic Intervention
Groot, P. H. E., Pearce, N., & Gribble, A. D. (2003) · Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents · doi:10.2174/1568013033483357 · Cited by 14
Bis[3-(4′-substituted phenyl)prop-2-ene]disulfides as a new class of antihyperlipidemic compounds
Sharma, M., Tiwari, M., & Chandra, R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.015 · Cited by 12
A Long‐Term Study of the Efficacy of Oxandrolone in Hyperlipoproteinemias
Malmendier, C. L., Bergen, C. J. V. D., EMPLIT, G., & Delcroix, C. (1978) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1978.tb01559.x · Cited by 11
Increase of latent HMG‐COA reductase activity with increasing density of cell cultures
Chen, H. W. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041170117 · Cited by 10
Design and synthesis of tricyclic derivatives as high density lipoprotein cholesterol enhancers
Elokdah, H. M., Chai, S., Ho, D. M., & Sulkowski, T. S. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00668-5 · Cited by 6
Cited by
Green Tea Catechins and Cardiovascular Health: An Update
Anandh Babu, P., & Liu, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132979 · Cited by 557
Sheng, H., & Sun, H. (2011) · Natural Product Reports · doi:10.1039/c0np00059k · Cited by 289
Kumari, S., Deori, M., Elancheran, R., Kotoky, J., & Devi, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00400 · Cited by 105
Zhou, Y., Cao, S., Wang, Y., Xu, P., Yan, J., Bin, W., Qiu, F., & Kang, N. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.11.010 · Cited by 81
Metadata
- Authors
- Jain, K. S., Kathiravan, M. K., Somani, R. S., & Shishoo, C. J.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 15
- Issue
- 14
- Pages
- 4674-4699
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W1978077064
- Cited by
- 264
- References
- 107
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.